KIRKMAN ROBERT L 4/A
4/A · Oncothyreon Inc. · Filed Mar 11, 2009
Insider Transaction Report
Form 4/AAmended
Oncothyreon Inc.ONTY
KIRKMAN ROBERT L
DirectorPresident/CEO
Transactions
- Award
Stock Option (right to buy)
2009-03-11+100,000→ 100,000 totalExercise: $1.11Exp: 2017-03-11→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]The option vests in four equal annual installments beginning on March 11, 2010.
- [F2]The Transaction Date, Transaction Code, Number of Derivative Securities Acquired and Price of Derivative Security were omitted from the reporting person's original Form 4.